NAFDAC Backs The Use Of Chloroquine To Fight COVID-19

Top News
Typography

The Director-General of National Agency for Food and Drug Administration and Control (NAFDAC) Mojisola Adeyeye has made the announcement that the Agency is not approving Chloroquine for the treatment of COVID-19 but for clinical trials to find treatment for the virus. This information was revealed by the DG in NAFDAC headquarters in Lagos.

NAFDAC has approved the production of chloroquine for clinical trials in the search for a cure for the pandemic COVID-19. Adeyeye called on experts and researchers that are willing in doing a clinical trial on Chloroquine to approach approved outlets.

BLOG COMMENTS POWERED BY DISQUS